Advice for Managing Schizophrenia in Clinics
August 25th 2025Panelists discuss how successful implementation of xanomeline/trospium chloride requires understanding its unique mechanism of action, providing proper patient education about dosing requirements, starting with slow titration, and recognizing it as an early treatment option rather than a last resort.
Watch
Postpartum Depression Resources for Providers and Patients
Experts discuss that Postpartum Support International is an invaluable resource offering education, training, and support to clinicians and families, while emphasizing the importance of strong local specialist networks for warm handoffs and streamlined referrals; combined with routine, repeated screening and proactive follow-up, these practices help reduce stigma and improve timely, compassionate care for perinatal mood disorders throughout pregnancy and postpartum.
Watch
Treatment Options and Monitoring Treatment Response in Postpartum Depression
Experts discuss that recent FDA-approved treatments like zuranolone offer rapid relief for postpartum depression, transforming care by enabling shorter, more effective pharmacologic courses; combined with tailored medication strategies, psychotherapy, and practical support around sleep and feeding, these advances promote comprehensive, individualized management that addresses both clinical symptoms and everyday challenges faced by new mothers
Watch
Treatment Barriers and Key Elements of Successful Treatment Plans in Postpartum Depression
Experts discuss that limited access to qualified prescribers, particularly in underserved areas, remains a major barrier to timely pharmacologic treatment for perinatal mental health, underscoring the need for collaborative care models that combine thoughtful assessment, supportive interventions like sleep and therapy, and ongoing follow-up to ensure individualized, effective management.
Watch
Best Practices for Schizophrenia Management
August 18th 2025Panelists discuss how best practices involve starting with lower doses in older patients, considering long-term tolerability over acute symptom control, and potentially using xanomeline/trospium chloride as first-line treatment even for treatment-naive patients presenting with acute psychosis.
Watch
A Case of a 52-Year-Old Female Patient With Schizophrenia
August 18th 2025Panelists discuss how Lila’s late-onset schizophrenia at age 52 raises diagnostic concerns requiring thorough medical workup, and how her response to olanzapine with sedation and shakiness suggests the need for dose reduction or consideration of alternative treatments such as xanomeline/trospium chloride.
Watch
Managing Postpartum Depression in Clinical Practice
Experts discuss that after a positive screen for perinatal mood or anxiety disorders, timely and compassionate intervention—through trusted resources like Postpartum Support International, thoughtful medication and therapy options, and patient-centered education that addresses stigma and supports shared decision-making—is key to achieving meaningful recovery and improved parent-infant outcomes.
Watch